Geneos Wealth Management’s Vertiv VRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$736K Buy
2,199
+18
+0.8% +$5.71K 0.02% 616
2026
Q1
$547K Buy
2,181
+202
+10% +$44.8K 0.01% 669
2025
Q4
$321K Buy
1,979
+237
+14% +$41.1K 0.01% 787
2025
Q3
$263K Sell
1,742
-1,752
-50% -$234K 0.01% 826
2025
Q2
$449K Buy
3,494
+251
+8% +$24.4K 0.01% 742
2025
Q1
$234K Buy
3,243
+1,096
+51% +$117K 0.01% 854
2024
Q4
$244K Buy
2,147
+1,115
+108% +$132K 0.01% 780
2024
Q3
$103K Buy
1,032
+902
+694% +$74.8K ﹤0.01% 958
2024
Q2
$11.3K Buy
+130
New +$11.8K ﹤0.01% 1517

Other funds holding VRT

Geneos Wealth Management's VRT Position: Q2 2026 in Review

Geneos Wealth Management increased its Vertiv (VRT) stake by 0.83% in Q2 2026, buying an estimated $5.71K and bringing the position to 2,199 shares worth $736K. The position accounts for 0.02% of the portfolio, ranked #616.

Geneos Wealth Management first reported a position in VRT in Q2 2024 and has held it in 9 quarters since. 2,061 funds tracked by Wall St. Rank hold VRT as of Q2 2026.

  • Geneos Wealth Management held 2,199 shares of Vertiv worth $736K as of Q2 2026.
  • Geneos Wealth Management bought 18 Vertiv shares in Q2 2026, an estimated $5.71K.
  • Vertiv made up 0.02% of Geneos Wealth Management's portfolio in Q2 2026, its #616 holding.
  • Geneos Wealth Management first reported a position in Vertiv in Q2 2024 and has held it in 9 quarters since.
  • 2,061 funds tracked by Wall St. Rank held Vertiv as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.